CELL CYCLE

Cell Cycle is a bi-weekly peer-reviewed journal of high priority research from all areas of cell biology. Cell Cycle covers all topics from yeast to man, from DNA to function, from development to aging, from stem cells to cell senescence, from metabolism to cell death, from cancer to neurobiology, from molecular biology to therapeutics. Our goal is fast publication of outstanding research. Cell Cycle has a prominent Editorial Board, which includes 3 Nobel Prize winners and other outstanding scientists. Launched in 2002 by its founding Editor and Editor-in-Chief, Mikhail V. Blagosklonny, Cell Cycle is now one of the largest journals in the field. Once bi-monthly, it is now bi-weekly (7000 papers on PubMed in 2015.) Categories of manuscripts include: Research papers/Reports Perspectives/Reviews Invited follow-ups to important articles published in Cell Cycle and elsewhere: Extra Views, Features, News and Views Cell Cycle offers online manuscript submission and peer-review by independent, anonymous expert referees, as well as a flexible open access policy. The journal is indexed by PubMed/Medline, Thomson Reuters, and Scopus. It is available both in the print and online formats. Cell Cycle will, at the discretion of the Chief Editor, consider reviewer reports from previous submission to other high-impact journals for accelerated review. High-priority papers will be peer-reviewed and published as soon as possible.